Shandong Zhushi Pharmaceutical Group Co.,Ltd
Shandong Zhushi Pharmaceutical Group Co., Ltd. is a large, diversified enterprise established in December 2005, headquartered in Heze, China. The group has grown to include a network of 21 subsidiaries and an expansive registered capital of 210 million yuan. Its operations span multiple locations, with key subsidiaries positioned in Tianjin, Ji’nan, Rizhao, and Shanxian. The company employs more than 2,100 people, among whom are 52 R&D professionals holding doctoral and master's degrees, underscoring a strong emphasis on research and development alongside manufacturing and distribution.
The corporate structure of Shandong Zhushi reflects a broad scope within the health and wellness sector. The group operates a diversified portfolio that encompasses plaster products, medical equipment, cosmetics, health foods, and drug development. It also engages in real estate development and biological reagents, illustrating a large-scale, integrated enterprise model that combines production with logistics and distribution capabilities. This integrated approach positions the group to coordinate end-to-end processes across its value chain, from product development through to market delivery.
A notable aspect of the group's operations is its comprehensive production and distribution platform, centered around a health industry park in Shandong. The park covers 560 acres and houses facilities for cosmetics, health foods, medical dressings, and medical polymer materials. The portfolio includes a range of medical devices and consumables such as safety syringes, indwelling needles, venous infusion apparatus, catheterization sets, vacuum blood collection vessels, disposable uterine cavity tissue suction tubes, chitosan-based wound dressings, nasal feeding tubes, stomach tubes, surgical masks, in vitro diagnostic reagents, and sanitary disinfection products. With more than 100 product series and over 300 varieties, the group has pursued significant scale and modernization targets, aiming to reach a scale capacity of seven billion yuan and to standardize production quality and management practices by 2020.
Shandong Zhushi Pharmaceutical Group emphasizes modernization and standardization as core strategic pillars. The company’s commitment to upgrading its production capabilities and quality management frameworks reflects a governance approach aligned with industry best practices and regulatory expectations for healthcare products. By integrating logistics distribution into its business model, the group seeks to streamline supply chain operations, enhance product traceability, and ensure reliable market access for its wide range of health-related products.
As a multi-faceted enterprise, Shandong Zhushi continues to balance its activities across manufacturing, research and development, logistics, and real estate development. This combination of capabilities enables the company to manage complex logistics demands inherent to healthcare products, including storage, handling of sensitive materials, and timely distribution to distributors and customers. While the group’s core activities are in health-related product development and production, its distributed subsidiary network and park-based manufacturing footprint provide a solid foundation for scalable operations and potential future expansion.
In summary, Shandong Zhushi Pharmaceutical Group Co., Ltd. represents a prominent, integrated Chinese conglomerate with deep roots in the pharmaceutical and healthcare sectors. Its expansive subsidiary network, strong emphasis on R&D, and large-scale production and distribution infrastructure position it as a key player within its regional market, with capabilities spanning product development, manufacturing, logistics, and related services across cosmetics, health foods, and medical devices.
